Intraportal 5-fluorouracil for colorectal cancer: the AXIS trial.

Intraportal 5-fluorouracil for colorectal cancer: the AXIS trial.

Bibliographic Details
Main Authors:	Garten, L, Stenning, S, Gray, R
Format:	Journal article
Language:	English
Published:	1992

Similar Items

Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS)
by: Miller, R, et al.
Published: (2003)

Efficacy of intraportal infusion for colon cancer: a fair assessment?
by: Marsoni, S, et al.
Published: (1991)

AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.
by: Gray, R, et al.
Published: (1991)

5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment
by: Yusefi, M., et al.
Published: (2021)

Intra-tumoural stromal morphometry predicts disease recurrence but not response to 5-fluorouracil - results from the QUASAR trial of colorectal cancer.
by: Hutchins, G, et al.
Published: (2017)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Bannur, Zakaria, et al.
Published: (2014)

Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
by: Lakshmi Chintala, et al.
Published: (2011-06-01)

Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer
by: Xingxing Huang, et al.
Published: (2022-06-01)

Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells
by: Sareh Kamran, et al.
Published: (2022-02-01)

Germline determinants of 5-fluorouracil drug toxicity and patient survival in colorectal cancer
by: Rosmarin, DN
Published: (2013)

ROLE OF INTRAPORTAL INFUSIONS IN COMPLEX CORRECTION OF A MACROPHAGE LIVER FAILURE AND ENDOTOXICOSIS AT WIDESPREAD PERITONITIS
by: V. N. Chernov, et al.
Published: (2014-03-01)

Jianpi Jiedu decoction reverses 5-fluorouracil resistance in colorectal cancer by suppressing the xCT/GSH/GPX4 axis to induce ferroptosis
by: Qin-ling Ou, et al.
Published: (2024-03-01)

Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance
by: Nijhuis, A, et al.
Published: (2017)

CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism
by: Shuohui Dong, et al.
Published: (2022-07-01)

Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction
by: Mohammad Arafat, et al.
Published: (2020-12-01)

Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma
by: Michal Hendrych, et al.
Published: (2022-09-01)

Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients
by: Teh, Lay Kek, et al.
Published: (2013)

Mannose Inhibits the Pentose Phosphate Pathway in Colorectal Cancer and Enhances Sensitivity to 5-Fluorouracil Therapy
by: Sadaf Al Hadeethi, et al.
Published: (2023-04-01)

ENO1 contributes to 5-fluorouracil resistance in colorectal cancer cells via EMT pathway
by: Jinrong Gu, et al.
Published: (2022-12-01)

Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
by: Yuanjue SUN, et al.
Published: (2009-04-01)

Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells
by: Lau, Meng Fei, et al.
Published: (2018)

The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy.
by: Grumett, SA, et al.
Published: (2001)

High-dosed nicotinamide decreases early graft failure after pig to nude rat intraportal islet transplantation.
by: Brandhorst, D, et al.
Published: (2002)

Prevention of intraportal islet failure by a highly selective iNOS inhibitor in the pig-to-nude rat model.
by: Brandhorst, D, et al.
Published: (2001)

ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
by: S. Lindsey Davis, et al.
Published: (2022-10-01)

PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil
by: Leah Schöckel, et al.
Published: (2024-02-01)

Radiosensitizing Effects of Irinotecan versus Oxaliplatin Alone and in Combination with 5-Fluorouracil on Human Colorectal Cancer Cells
by: Bernd Frerker, et al.
Published: (2023-06-01)

Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
by: Yasushi Hamaya, et al.
Published: (2015-01-01)

The Impact of Thymidylate Synthase and Methylenetetrahydrofolate Reductase Genotypes on Sensitivity to 5-Fluorouracil Treatment in Colorectal Cancer Cells
by: Fakhraddin Naghibalhossaini, et al.
Published: (2018-01-01)

Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
by: Wen Peng, et al.
Published: (2020-07-01)

In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells
by: Monica Susan, et al.
Published: (2023-06-01)

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.
by: Fernandez-Rozadilla, C, et al.
Published: (2013)

Pharmacogenomics in colorectal cancer: A genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
by: Fernandez-Rozadilla, C, et al.
Published: (2013)

The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts
by: Geert A. Martens, et al.
Published: (2021-07-01)

Hyaluronic acid‐decorated liposomal nanoparticles for targeted delivery of 5‐fluorouracil into HT‐29 colorectal cancer cells
by: Mansoori, Behzad, et al.
Published: (2022)

Hyaluronic acid‐decorated liposomal nanoparticles for targeted delivery of 5‐fluorouracil into HT‐29 colorectal cancer cells
by: Mansoori, Behzad, et al.
Published: (2022)

Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
by: Arnott, S, et al.
Published: (1996)

Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways
by: Weijia Zhang, et al.
Published: (2023-06-01)

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
by: Kerr, D, et al.
Published: (2003)

5-Fluorouracil encapsulated chitosan-cellulose fiber bionanocomposites: synthesis, characterization and in vitro analysis towards colorectal cancer cells
by: Yusefi, M., et al.
Published: (2021)